Carolinas Wealth Consulting’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-34
Closed -$423 1116
2022
Q4
$423 Buy
+34
New +$434 ﹤0.01% 1021

Other funds holding SBRA

Carolinas Wealth Consulting's SBRA Position: Q1 2023 in Review

Carolinas Wealth Consulting sold out of Sabra Healthcare REIT (SBRA) in Q1 2023, closing a stake of 34 shares — an estimated $423 sold.

Carolinas Wealth Consulting first reported a position in SBRA in Q4 2022 and held it in 1 quarter. The position peaked at $423 in Q4 2022. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2023.

  • Carolinas Wealth Consulting reported no remaining Sabra Healthcare REIT position as of Q1 2023 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 34 Sabra Healthcare REIT shares in Q1 2023, an estimated $423.
  • Carolinas Wealth Consulting first reported a position in Sabra Healthcare REIT in Q4 2022 and held it in 1 quarter.
  • Carolinas Wealth Consulting's Sabra Healthcare REIT position peaked at $423 in Q4 2022.
  • 324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2023.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2023, filed 16 May 2023.